2014 | | Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP. | 강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2014 | | Clinical outcomes and prognostic factors of empirical antifungal therapy with itraconazole in the patients with hematological malignancies: a prospective multicenter observational study in Korea. | 박준성 |
2014 | | A novel delivery platform for therapeutic peptides. | 박준성 |
2014 | | Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial | 최진혁 |
2014 | | Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial. | 강석윤 |
2013 | | Double-filtration plasmapheresis for the treatment of patients with recalcitrant atopic dermatitis. | 남동호, 박준성 |
2013 | | Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression. | 강석윤, 김장희, 박태준, 임현이, 정용식 |
2013 | | 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection. | 강석윤, 박준성, 안미선, 이광재, 이순영, 이현우, 정성현, 조용관, 최진혁, 한상욱 |
2013 | | Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02. | 강석윤 |
2013 | | A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer. | 강석윤 |
2013 | | Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib. | 박준성, 정성현 |
2013 | | Wnt5a stimulates chemotactic migration and chemokine production in human neutrophils. | 박준성 |
2013 | | Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905). | 강석윤 |
2013 | | Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells. | 김성수, 김세혁, 박준성, 서해영, 이영돈, 장다영 |
2013 | | Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients. | 박준성 |
2013 | | Role of CXCR2 on the immune modulating activity of α-iso-cubebenol a natural compound isolated from the Schisandra chinensis fruit. | 박준성 |
2013 | | Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry | 김효철 |
2013 | | Current routine practice and clinico-pathological characteristics associated with acute promyelocytic leukemia in Korea | 박준성, 박준은, 이현우, 정성현, 조성란 |
2013 | | Granulocytic sarcoma in breast after bone marrow transplantation. | 강두경, 강석윤, 김구상, 김태희, 임현이, 정성현, 정용식 |
2013 | | Usefulness of 18F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases | 강석윤, 김구상, 안영실, 윤준기, 이수진 |